StockNews.AI
ABL
StockNews.AI
2 days

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abacus Global Management, Inc.- ABL

1. Pomerantz LLP investigates potential securities fraud claims against Abacus Global Management. 2. A report alleges Abacus manipulated portfolio valuation to misrepresent profitability. 3. Abacus’s stock fell 21.47% following the negative report on June 5, 2025. 4. Concerns raised over questionable life expectancy calculations by Abacus. 5. Investors may participate in a class action for potential legal recourse.

4m saved
Insight
Article

FAQ

Why Very Bearish?

The investigation into Abacus for potential fraud and significant stock drop indicate serious issues. Historical parallels exist with companies like Enron, where similar investigations led to massive share price declines.

How important is it?

The significant concerns raised and immediate stock impact suggest high relevance to ABL investors. Ongoing legal actions can heavily influence investor sentiment and stock performance.

Why Short Term?

The immediate impact of negative news usually results in quick stock reaction. Past experiences show strong short-term declines after investigations are announced.

Related Companies

SPACABACCLOLIFE
NEW YORK, Aug. 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Abacus Global Management, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Abacus and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class action] On June 4, 2025, Morpheus Research a report entitled “Abacus Global Management: This $794 Million SPAC Is Yet Another Life Settlements Accounting Scheme Manufacturing Fake Revenue By Systematically Underestimating When People Will Die.”  The report alleges that Abacus incorporated a change in its portfolio valuation methodology to make Abacus appear more profitable that it actually is.  The report also alleges that Abacus uses questionable methodologies for calculating life expectancy estimates and identified historical “red flags” associated with Abacus’s co-founders.  On this news, Abacus’s stock price fell $1.64 per share, or 21.47%, to close at $6.00 per share on June 5, 2025. Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com. Attorney advertising. Prior results do not guarantee similar outcomes. CONTACTDanielle PeytonPomerantz LLPdpeyton@pomlaw.com646-581-9980 ext. 7980   

Related News